Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Camille Harfouche"'
Autor:
Ahmad Subhi, Amin Mohamed El Shamy, Saeed Abdullah Mohammed Hussein, James Jarrett, Sam Kozma, Camille Harfouche, Sara Al Dallal
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background This study attempts to estimate the cost-effectiveness of the antiviral remdesivir, as recommended in the 2021 COVID treatment guidelines for the United Arab Emirates, compared to standard of care (SOC), but also favipiravir (FAVI
Externí odkaz:
https://doaj.org/article/d2e2d4cfd6c64b0db1c530961ddaead2
Autor:
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Basem Alraddadi, Alaa Alali, James Jarrett, Sam Kozma, Camille Harfouche, Tariq Al Musawi
Publikováno v:
Clinical Drug Investigation.
Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Saudi Arabia was significantly impacted by COVID-19. In March 2021, 381,000 cases were reported with 6539 deaths. This study attempts to quantify the impact of remdesivir on healthcare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef8376b7b3dd6620d2de90c64656d27
https://doi.org/10.1007/s40261-022-01177-z
https://doi.org/10.1007/s40261-022-01177-z
Autor:
Alessandro Signorini, Silvia Caravaggio, Sam Kozma, Camille Harfouche, Matteo Ruggeri, Basem Alraddadi, Alaa Alali, Tariq AlMusawi
Publikováno v:
International Journal of Antimicrobial Agents. 58:21003484
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::287efe0afbb3c916c8fd8ae6d8efae7a
https://doi.org/10.1016/j.ijantimicag.2021.106421.77
https://doi.org/10.1016/j.ijantimicag.2021.106421.77